Show
Sort by
-
Safety and efficacy of nipocalimab in adults with generalised myasthenia gravis (Vivacity-MG3) : a phase 3, randomised, double-blind, placebo-controlled study
-
- Journal Article
- A1
- open access
Long-term safety, tolerability, and efficacy of efgartigimod (ADAPT+) : interim results from a phase 3 open-label extension study in participants with generalized myasthenia gravis
-
Safety and efficacy of oral levosimendan in people with amyotrophic lateral sclerosis (the REFALS study) : a randomised, double-blind, placebo-controlled phase 3 trial
-
Safety, efficacy, and tolerability of efgartigimod in patients with generalised myasthenia gravis (ADAPT) : a multicentre, randomised, placebo-controlled, phase 3 trial
-
- Miscellaneous
- open access
Introduction to the special issue 'In-depth study of air pollution sources and processes within Beijing and its surrounding region (APHH-Beijing)'